Kent Imaging, a near -infrared tissue oxygenation and bacterial autofluorescence imaging company, has partnered with Marathon Medical Corporation, a service-disabled veteran-owned small business specialising in federal healthcare distribution.
“This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community,” said Kent Imaging CEO Pierre Lemire.
The partnership combines Kent Imaging’s point-of-care tissue assessment devices, SnapshotNIR and SnapshotGLO with Marathon Medical’s experience in federal healthcare. Together, the organisations will expand access to Kent Imaging’s advanced wound imaging technologies across the US Department of Veterans Affairs (VA) healthcare facilities.
“At Marathon Medical, our mission has always been to serve those who served. We are pleased to have Kent Imaging’s Snapshot suite as part of that mission,” said Marathon Medical chief commercialisation officer Jon Landis.
Chronic wounds and lower extremity complications remain a significant health concern in the veteran population, particularly among patients living with diabetes and peripheral arterial disease.
By providing clinicians with information about tissue oxygenation and bacterial burden, Kent Imaging’s solutions help to support earlier clinical decision-making, improve healing outcomes and reduce preventable amputations.
